← Open Payments lookup

LAEL REYNOLDS: Open Payments

NPI 1689332769 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$941 in 51 payments from 10 companies in 2025. Trend: 2023 $970 · 2024 $1,138 · 2025 $941

Food & beverage: $941
CompanyPaymentsAmount
ABBVIE INC.18$247
Neurocrine BioSciences, Inc.10$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$114
Axsome Therapeutics, Inc.3$94
Otsuka America Pharmaceutical, Inc.4$91
Alkermes, Inc.3$79
Teva Pharmaceuticals USA, Inc.4$62
Lundbeck LLC2$38
Vanda Pharmaceuticals Inc.1$31
Indivior Inc.1$16

Products named: VRAYLAR, INGREZZA, CAPLYTA, Auvelity, REXULTI, LYBALVI, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across ID — which companies pay providers there.